NCT04251780View on ClinicalTrials.gov

Tissue K+ in Primary Hyperaldosteronism

NARecruitingINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2023

Conditions
Primary HyperaldosteronismElectrolyte Disturbance
Interventions
PROCEDURE

Surgical Treatment of Hyperaldosteronism

Surgery of an Aldosterone-producing adenoma

DRUG

Drug treatment of Hyperaldosteronism

Treatment of Hyperaldosteronism with Spironolactone or Eplerenone.

Trial Locations (2)

91054

RECRUITING

Nephrology Department, University Hospital Erlangen, Erlangen

RECRUITING

Radiology Department, University Hospital Erlangen, Erlangen

All Listed Sponsors
lead

University of Erlangen-Nürnberg Medical School

OTHER